Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Jounce Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 669.9K | 0 | −669.9K (−100.0%) |
| Value | $917.8K | $0 | −$917.8K (−100.0%) |
New holders (0)
Institutions that held Jounce Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (1)
Institutions that held Jounce Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Opaleye Management Inc. | 669,944 | $917.8K |